QR Code (код быстрого отклика)

The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management

Purpose: Lymphoma, the most predominant neoplastic disorder, is divided into Hodgkin and Non-Hodgkin Lymphoma classifications. Immunotherapeutic modalities have emerged as essential methodologies in combating lymphoid malignancies. Chimeric Antigen Receptor (CAR) T cells exhibit promising responses...

Полное описание

Сохранить в:
Главные авторы: Dito Anurogo, Dewi Luthfiana, Nuralfin Anripa, Apriliani Ismi Fauziah, Maratu Soleha, Laila Rahmah, Hana Ratnawati, Teresa Liliana Wargasetia, Sari Eka Pratiwi, Riswal Nafi Siregar, Ratis Nour Sholichah, Muhammad Sobri Maulana, Taruna Ikrar, Yu Hsiang Chang, Jiantai Timothy Qiu
Формат: Artigo
Язык:Inglês
Опубликовано: Tabriz University of Medical Sciences 2024-07-01
Серии:Advanced Pharmaceutical Bulletin
Предметы:
car-t cells
lymphoma
management
Online-ссылка:https://apb.tbzmed.ac.ir/PDF/apb-14-314.pdf
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы